Confirmation of Preliminary Results

RNS Number : 1460V

Omega Diagnostics Group PLC

08 August 2022

 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Confirmation of Preliminary Results

Investor Presentation

Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition products, confirms it will issue its preliminary results for the year ended 31 March 2022 on Thursday 18 August 2022.

Investor presentation

Jag Grewal, CEO and Chris Lea, CFO will provide a live presentation relating to the preliminary Results via the Investor Meet Company platform on Thursday 18 August 2022 at 4:30pm BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Omega Diagnostics Group plc via: 

https://www.investormeetcompany.com/omega-diagnostics-group-plc/register-investor  

Investors who already follow Omega Diagnostics Group plc on the Investor Meet Company platform will automatically be invited.

Contacts: 

Omega Diagnostics Group PLC		www.omegadx.com
Jag Grewal, Chief Executive Officer		via Walbrook PR
Chris Lea, Chief Financial Officer
finnCap Ltd		Tel: [phone]
Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance)
Alice Lane/ Harriet Ward (ECM)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Lianne Applegarth		Mob: [phone]
Sam Allen		Mob: [phone]

About Omega Diagnostics Group PLC

Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 70 countries and is now focused on the health and nutrition sector.

www.omegadx.com

 

END

 

 

NORBSGDILXGDGDU